DOI: 10.12890/2021_002839

Cardiac Sodium Channel Blockade Due to Antiepileptic Drug Combination

Authors

  • Ossama Maadarani Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Al Ahmadi, Kuwait
  • Zouheir Bitar nternal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Al Ahmadi, Kuwait
  • Abdelaziz Ashkanani Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Al Ahmadi, Kuwait
  • Mahmoud Elzoueiry nternal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Al Ahmadi, Kuwait
  • Mohamad Elhabibi Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Al Ahmadi, Kuwait
  • Mohammad Gohar Internal Medicine Department, Ahmadi Hospital, Kuwait Oil Company, Al Ahmadi, Kuwait
  • Mohamad Almuwaiziri Nursing Department, Ahmadi Hospital, Kuwait Oil Company, Al Ahmadi, Kuwait
  • Sania Soeb nternal Medicine Department, Al Salam Hospital, Kuwait
  • Jadan Alsaddah Department of Cardiology, Chest Diseases Hospital, Kuwait

omaadarani@kockw.com

Keywords

Sodium channel blockers, lacosamide, electrocardiogram

Abstract

Drugs that inhibit voltage-dependent sodium channels are commonly used to treat epilepsy. Old and novel antiepileptic drugs are used either as monotherapy or in combination to control epilepsy. For a long time, carbamazepine has been used as the first choice for the treatment of simple and complex partial seizures. In the USA, lacosamide was approved in October 2008 as an adjunctive treatment for partial-onset seizures. We describe the effect of two sodium channel blockers on the heart of a patient with epilepsy.

View the entire article

Downloads

References

  1. Kwan P, Schachter SC, Brodie MJ. Drug-resistant epilepsy. N Engl J Med 2011;365:919–926.
  2. Brodie MJ. Pharmacological treatment of drug-resistant epilepsy in adults: a practical guide. Curr Neurol Neurosci Rep 2016;16:82.
  3. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2003;2:347–356.
  4. Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM, et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science 2016;351(6271):403–407.
  5. Beyreuther BK, Freitag J, Heers C, Krebsfänger N, Scharfenecker U, Stöhr T. Lacosamide: a review of preclinical properties. CNS Drug Rev 2007;13:21–42.
  6. Sheets PL, Heers C, Stoehr T, Cummins TR. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)- N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J Pharmacol Exp Ther 2008;326:89–99.
  7. Tomson T, Kenneback G. Arrhythmia, heart rate variability, and antiepileptic drugs. Epilepsia 1997;38:S48–51.
  8. DeGiorgio AM, Dessoa TE, Lee L, DeGiorgio CM. Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy. Epilepsy Behav Case Rep 2013;1:26–28.
  9. Nizam A, Mylavarapu K, Thomas D, Briskin K, Wu B, Saluja D, et al. Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy. Epilepsia 2011;52:153–155.

Published

2021-10-04

Issue

Vol. 8 No. 10 (2021)

How to Cite

1.
Maadarani O, Bitar Z, Ashkanani A, Elzoueiry M, Elhabibi M, Gohar M, et al. Cardiac Sodium Channel Blockade Due to Antiepileptic Drug Combination. EJCRIM [Internet]. 2021 Oct. 4 [cited 2026 Nov. 4];8(10). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2839

Most read articles by the same author(s)

1 2 > >>